A Deadline is coming up on March 6, 2023 in the lawsuit for certain investors in BioLineRx Ltd. (NASDAQ:BLRX).
San Diego, CA -- (SBWIRE) -- 02/21/2023 -- A deadline is coming up on March 6, 2023 in the lawsuit filed for certain investors of BioLineRx Ltd. (NASDAQ: BLRX).
Investors who purchased shares of BioLineRx Ltd. (NASDAQ: BLRX) have certain options and there are strict and short deadlines running. Deadline: March 6, 2023. NASDAQ: BLRX stockholders should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of BioLineRx Ltd. (NASDAQ: BLRX) common shares between February 23, 2021 and September 19, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 23, 2021 and September 19, 2022, the defendants made false and/or misleading statements and/or failed to disclose, among other things, that the Company was not well financed to develop Motixafortide while at the same time advancing other pipeline programs, that BioLine would require a loan from Kreos Capital VII Aggregator SCSP in an aggregate principal amount of up to $40 million and then also would require a $15M securities offering to facilitate the commercial launch of Motixafortide, and that as a result of the foregoing, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Those who purchased shares of BioLineRx Ltd. (NASDAQ: BLRX) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.